DCIS Recorded Webcast

Recorded: November 12, 2018

 

Pat Whitworth and Michael Alvarado hosted a discussion with a panel of TME breast surgeons and Rick Baehner M.D., VP of Development Oncology and Pathology at Genomic Health and Assistant Professor of Pathology at UCSF. The panel focused on ways to implement molecular testing for DCIS in routine practice. The panelists also discussed how to educate DCIS patients regarding risk of recurrence and potential radiation benefit using the Oncotype DCIS Score™.

 

The test reports individualized risk of recurrence and invasive recurrence by integrating DCIS Score, plus patient-age-at-diagnosis, plus size of tumor-- all of which impact recurrence (but not overall survival). The clinicopathologic factors of age and size were integrated with the DCIS Score™ result to provide a refined estimate of the 10-year risk of local recurrence after breast-conserving surgery to help guide treatment decision making.

 

This webcast also provided an overview of the validation and data supporting the Oncotype DX® Breast DCIS Score™ test, including the latest analysis of the ECOG E5194 and Ontario DCIS cohort studies.